- Home
- Publications
- Publication Search
- Publication Details
Title
SHH inhibitors for the treatment of medulloblastoma
Authors
Keywords
-
Journal
Expert Review of Neurotherapeutics
Volume 15, Issue 7, Pages 763-770
Publisher
Informa UK Limited
Online
2015-06-01
DOI
10.1586/14737175.2015.1052796
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Emergence of chemoresistance in a metastatic basal cell carcinoma patient after complete response to hedgehog pathway inhibitor vismodegib (GDC-0449)
- (2014) Rowena E Meani et al. AUSTRALASIAN JOURNAL OF DERMATOLOGY
- Inhibition of Hedgehog signalling by NVP-LDE225 (Erismodegib) interferes with growth and invasion of human renal cell carcinoma cells
- (2014) C D’Amato et al. BRITISH JOURNAL OF CANCER
- Genome Sequencing of SHH Medulloblastoma Predicts Genotype-Related Response to Smoothened Inhibition
- (2014) Marcel Kool et al. CANCER CELL
- Pemetrexed and Gemcitabine as Combination Therapy for the Treatment of Group3 Medulloblastoma
- (2014) Marie Morfouace et al. CANCER CELL
- Foretinib Is Effective Therapy for Metastatic Sonic Hedgehog Medulloblastoma
- (2014) C. C. Faria et al. CANCER RESEARCH
- A Phase I Study of PF-04449913, an Oral Hedgehog Inhibitor, in Patients with Advanced Solid Tumors
- (2014) A. J. Wagner et al. CLINICAL CANCER RESEARCH
- Phase I Dose-Escalation Trial of the Oral Investigational Hedgehog Signaling Pathway Inhibitor TAK-441 in Patients with Advanced Solid Tumors
- (2014) J. Goldman et al. CLINICAL CANCER RESEARCH
- Pilot Clinical Trial of Hedgehog Pathway Inhibitor GDC-0449 (Vismodegib) in Combination with Gemcitabine in Patients with Metastatic Pancreatic Adenocarcinoma
- (2014) E. J. Kim et al. CLINICAL CANCER RESEARCH
- Molecular Insights into Pediatric Brain Tumors Have the Potential to Transform Therapy
- (2014) A. Gajjar et al. CLINICAL CANCER RESEARCH
- Germline Mutations inSUFUCause Gorlin Syndrome–Associated Childhood Medulloblastoma and Redefine the Risk Associated WithPTCH1Mutations
- (2014) Miriam J. Smith et al. JOURNAL OF CLINICAL ONCOLOGY
- Cytogenetic Prognostication Within Medulloblastoma Subgroups
- (2014) David J.H. Shih et al. JOURNAL OF CLINICAL ONCOLOGY
- Impact of Craniospinal Dose, Boost Volume, and Neurologic Complications on Intellectual Outcome in Patients With Medulloblastoma
- (2014) Iska Moxon-Emre et al. JOURNAL OF CLINICAL ONCOLOGY
- Repurposing the Antihelmintic Mebendazole as a Hedgehog Inhibitor
- (2014) A. R. Larsen et al. MOLECULAR CANCER THERAPEUTICS
- Hedgehog Pathway Inhibition in Chondrosarcoma Using the Smoothened Inhibitor IPI-926 Directly Inhibits Sarcoma Cell Growth
- (2014) V. T. Campbell et al. MOLECULAR CANCER THERAPEUTICS
- Epigenetic targeting of Hedgehog pathway transcriptional output through BET bromodomain inhibition
- (2014) Yujie Tang et al. NATURE MEDICINE
- Medulloblastoma—translating discoveries from the bench to the bedside
- (2014) Amar J. Gajjar et al. Nature Reviews Clinical Oncology
- Effective treatment of diverse medulloblastoma models with mebendazole and its impact on tumor angiogenesis
- (2014) Ren-Yuan Bai et al. NEURO-ONCOLOGY
- Inhibition of the MET Receptor Tyrosine Kinase as a Novel Therapeutic Strategy in Medulloblastoma
- (2014) Paul N. Kongkham et al. Translational Oncology
- Itraconazole and Arsenic Trioxide Inhibit Hedgehog Pathway Activation and Tumor Growth Associated with Acquired Resistance to Smoothened Antagonists
- (2013) James Kim et al. CANCER CELL
- Targeting Sonic Hedgehog-Associated Medulloblastoma through Inhibition of Aurora and Polo-like Kinases
- (2013) S. L. Markant et al. CANCER RESEARCH
- Phase I Study of the Hedgehog Pathway Inhibitor IPI-926 in Adult Patients with Solid Tumors
- (2013) A. Jimeno et al. CLINICAL CANCER RESEARCH
- Phase I Study of Vismodegib in Children with Recurrent or Refractory Medulloblastoma: A Pediatric Brain Tumor Consortium Study
- (2013) A. Gajjar et al. CLINICAL CANCER RESEARCH
- Medulloblastoma molecular dissection
- (2013) Marc Remke et al. CURRENT OPINION IN ONCOLOGY
- Inhibition mechanism exploration of investigational drug TAK-441 as inhibitor against Vismodegib-resistant Smoothened mutant
- (2013) Tsuyoshi Ishii et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- TAK-441, a novel investigational smoothened antagonist, delays castration-resistant progression in prostate cancer by disrupting paracrine hedgehog signaling
- (2013) Naokazu Ibuki et al. INTERNATIONAL JOURNAL OF CANCER
- Processing Speed, Attention, and Working Memory After Treatment for Medulloblastoma: An International, Prospective, and Longitudinal Study
- (2013) Shawna L. Palmer et al. JOURNAL OF CLINICAL ONCOLOGY
- Physical functioning in pediatric survivors of childhood posterior fossa brain tumors
- (2013) P. J. Piscione et al. NEURO-ONCOLOGY
- Targeting hedgehog signaling in cancer: research and clinical developments
- (2013) Jingwu Xie et al. OncoTargets and Therapy
- Molecular subgroups of medulloblastoma: an international meta-analysis of transcriptome, genetic aberrations, and clinical data of WNT, SHH, Group 3, and Group 4 medulloblastomas
- (2012) Marcel Kool et al. ACTA NEUROPATHOLOGICA
- A Randomized Phase II Trial of Vismodegib versus Placebo with FOLFOX or FOLFIRI and Bevacizumab in Patients with Previously Untreated Metastatic Colorectal Cancer
- (2012) J. Berlin et al. CLINICAL CANCER RESEARCH
- High Frequency of Germline SUFU Mutations in Children With Desmoplastic/Nodular Medulloblastoma Younger Than 3 Years of Age
- (2012) Laurence Brugières et al. JOURNAL OF CLINICAL ONCOLOGY
- Novel mutations target distinct subgroups of medulloblastoma
- (2012) Giles Robinson et al. NATURE
- Subgroup-specific structural variation across 1,000 medulloblastoma genomes
- (2012) Paul A. Northcott et al. NATURE
- The clinical implications of medulloblastoma subgroups
- (2012) Paul A. Northcott et al. Nature Reviews Neurology
- Efficacy and Safety of Vismodegib in Advanced Basal-Cell Carcinoma
- (2012) Aleksandar Sekulic et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Utility of Hedgehog Signaling Pathway Inhibition for Cancer
- (2012) S. Sahebjam et al. ONCOLOGIST
- Medulloblastoma stem cells: where development and cancer cross pathways
- (2012) Branavan Manoranjan et al. PEDIATRIC RESEARCH
- Hedgehog pathway inhibitor saridegib (IPI-926) increases lifespan in a mouse medulloblastoma model
- (2012) M. J. Lee et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Hedgehog pathway as a drug target: Smoothened inhibitors in development
- (2012) Tara Lin et al. OncoTargets and Therapy
- Molecular subgroups of medulloblastoma: the current consensus
- (2011) Michael D. Taylor et al. ACTA NEUROPATHOLOGICA
- Sonic hedgehog regulates Bmi1 in human medulloblastoma brain tumor-initiating cells
- (2011) X Wang et al. ONCOGENE
- Survival and Prognostic Factors of Early Childhood Medulloblastoma: An International Meta-Analysis
- (2010) Stefan Rutkowski et al. JOURNAL OF CLINICAL ONCOLOGY
- Arsenic antagonizes the Hedgehog pathway by preventing ciliary accumulation and reducing stability of the Gli2 transcriptional effector
- (2010) J. Kim et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Interfering with Resistance to Smoothened Antagonists by Inhibition of the PI3K Pathway in Medulloblastoma
- (2010) S. Buonamici et al. Science Translational Medicine
- Discovery of NVP-LDE225, a Potent and Selective Smoothened Antagonist
- (2010) Shifeng Pan et al. ACS Medicinal Chemistry Letters
- Discovery of a Potent and Orally Active Hedgehog Pathway Antagonist (IPI-926)
- (2009) Martin R. Tremblay et al. JOURNAL OF MEDICINAL CHEMISTRY
- Treatment of Medulloblastoma with Hedgehog Pathway Inhibitor GDC-0449
- (2009) Charles M. Rudin et al. NEW ENGLAND JOURNAL OF MEDICINE
- Smoothened Mutation Confers Resistance to a Hedgehog Pathway Inhibitor in Medulloblastoma
- (2009) R. L. Yauch et al. SCIENCE
- Management of and Prognosis With Medulloblastoma
- (2008) Roger J. Packer et al. ARCHIVES OF NEUROLOGY
- Transient Inhibition of the Hedgehog Pathway in Young Mice Causes Permanent Defects in Bone Structure
- (2008) Hiromichi Kimura et al. CANCER CELL
- Hedgehog: functions and mechanisms
- (2008) M. Varjosalo et al. GENES & DEVELOPMENT
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now